The Globe and Mail reports in its Thursday edition that Canaccord Genuity analyst Aravinda Galappatthige has lowered his recommendation for Thomson Reuters to "hold" from "buy." The Globe's David Leeder writes in the Eye On Equities column that Mr. Galappatthige gave his share target a $7 boost to $131 (all figures U.S.). Analysts on average target the shares at $129.45. Following in-line first quarter financial results, Mr. Galappatthige sees Thomson Reuters on track to meeting its full-year financial guidance. He thinks, however, that "much of the good news is already priced in" after "aggressive shareholder returns policies and strong execution operationally have driven up" its shares. Mr. Galappatthige recommends investors wait for a "more compelling entry point." Mr. Galappatthige says in a note: "Confidence around meeting guidance remains strong: Despite a backdrop of slowing macro conditions and some lengthening in sales cycles, we believe the Q1 result are supportive of meeting full-year expectations. We found the 38.8-per-cent EBITDA margin in Q1 encouraging given the newly acquired (and low margin) SurePrep business generates half of its revenues in this quarter and would have served as a headwind."